ask="16.83"
ask_size="400"
average_daily_volume="564719"
bid="N/A"
bid_size="N/A"
book_value="9.23"
change="-0.03"
change_from_200_day_moving_average="-9.72"
change_from_50_day_moving_average="-1.10"
change_from_52_week_high="-31.58"
change_From_52_week_low="2.82"
change_in_percent="-0.22%"
close="13.62"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.73"
ebitda="-119.41M"
eps_estimate_current_year="-2.82"
eps_estimate_next_quarter="-0.80"
eps_estimate_next_year="-3.28"
ex_dividend_date="N/A"
float_shares="33576000"
high="13.81"
high_52_weeks="45.20"
last_trade_date="2/10/2017"
last_trade_price="13.62"
last_trade_size="9232"
last_trade_time="4:00pm"
low="13.53"
low_52_weeks="10.80"
market_capitalization="589.31M"
moving_average_200_day="23.34"
moving_average_50_day="14.72"
name="Intra-Cellular Therapies Inc."
notes="N/A"
one_year_target_price="35.63"
open="13.68"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-41.64%"
percent_change_from_50_day_moving_average="-7.47%"
percent_change_from_52_week_high="-69.87%"
percent_change_from_52_week_low="+26.11%"
previous_close="13.65"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.48"
price_per_sales="2241.69"
revenue="263466.00"
shares_outstanding="43268000"
short_ratio="8.31"
stock_exchange="NMS"
symbol="ITCI"
volume="277958"
weeks_range_52="10.80 - 45.20"
